🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. Rivastigmine transdermal patch

    Novartis Pharmaceuticals

    Alzheimer's Disease

    approved small molecule completed

    1 trial

  2. Rocuronium

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  3. Rocuronium Bromide

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  4. Rosuvastatin and Ezetimibe morning or evening administration

    COLLEGIUM PHARMACEUTICAL, INC

    Hypercholesterolemia

    approved small molecule completed

    1 trial

  5. SEG101

    Novartis Pharmaceuticals

    Sickle cell disease

    approved small molecule active

    1 trial

  6. SIS-reinforced anastomosis

    Rocket Pharmaceuticals B.V.

    Rectal Cancer

    approved other active

    1 trial

  7. SPN-538

    SUPERNUS PHARMACEUTICALS, INC.

    Migraine Disorders

    approved small molecule terminated

    1 trial

  8. SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule active

    3 trials

  9. SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  10. SPN-812 (600mg, QD)

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Lactating Women

    approved small molecule completed

    1 trial

  11. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  12. Search AV+ algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Sinus

    approved other terminated

    1 trial

  13. Secukinumab s.c. injection

    Novartis Pharmaceuticals

    Autoimmunity, Inflammation

    approved mab active

    1 trial

  14. Sequential Icotinib Plus Chemotherapy

    Betta Pharmaceuticals Co.,

    EGFR Positive Non-small Cell Lung Cancer

    approved small molecule active

    1 trial

  15. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Healthy

    approved small molecule completed

    1 trial

  16. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    REM Sleep Behavior Disorder

    approved small molecule completed

    1 trial

  17. Solriamfetol

    Jazz Pharmaceuticals Ireland Limited

    Binge Eating Disorder

    approved small molecule active

    1 trial

  18. SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation

    Ningbo Cancer Hospital

    Gastroenteropancreatic neuroendocrine tumors

    approved small molecule active

    1 trial

  19. Stent

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Disease

    approved other completed

    1 trial

  20. Subcutaneous depot medroxyprogesterone acetate

    Protara Therapeutics

    Contraception

    approved small molecule completed

    1 trial

  21. Sulforaphane

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    HIV Infections

    approved small molecule active

    1 trial

  22. Suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Acute Pain

    approved small molecule completed

    2 trials

  23. Suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    approved small molecule active

    6 trials

  24. TACROLIMUS, SIROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, PREDNISOLONE, EVEROLIMUS, MYCOPHENOLIC ACID, BELATACEPT, CICLOSPORIN

    The George Institute

    BK Polyomavirus DNAemia after kidney transplantation

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources